Comment: Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease

Abstract

Get full access to this article

View all access options for this article.

References

Schafer

Casey

Dupre

Staubes

. Safety and efficacy of apixaban versus warfarin in patients with advanced chronic kidney disease. Ann Pharmacother. 2019;53:104.

Yao

Shah

Sangaralingham

Gersh

Noseworthy

PA.

Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. J Am Coll Cardiol. 2017;69:2779-2790.

Siontis

Zhang

Eckard

et al . Outcomes associated with apixaban use in end-stage kidney disease patients with atrial fibrillation in the United States. Circulation. 2018;138:1519-1529.